Patrys Share Price and Company Fundamentals

0.000 (0.000%)
52 week
0.021 - 0.063

Last traded: Today at 4:45 AM

Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates cell nuclei and inhibits mechanisms of DNA repair in target cancer cells. The company also focuses on developing PAT-DX1, an antibody fragment for the treatment of primary and secondary brain cancer, triple negative breast cancer, and glioblastoma. In addition, it is developing PAT-DX3, a full-sized antibody that has DNA-binding and DNA damage repair blocking properties of PAT-DX1 used for tissue distribution, pharmacokinetic profile, etc.; and PAT-DX1-NP, a product based on the targeted delivery of nanoparticles carrying therapeutic payloads to the inside of cancer cells. Patrys Limited has a collaborative research program with Imagion Biosystems Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis. The company was incorporated in 2006 and is based in Melbourne, Australia.

Key Metrics

PE ratio


PB ratio


Dividend yield



Market cap


Enterprise value


Company profile

Primary activitiesDevelopment of natural human antibody-based therapies for the treatment of life threatening diseases including cancer.
Industry / SectorBiotechnology / Healthcare
Mailing address100 Albert Road Level 4 Melbourne VIC 3205 Australia
Phone / Fax61 3 9670 3273 / 61 3 9077 9233


Patrys does not pay dividends.

Company Executives

As of Jan 2022, following are the company executives and directors listed on Patrys.

NameTitleAgeTotal Pay
Dr. James A. Campbell B.Sc., MBA, Ph.D.MD, CEO & Exec. Director528.7k
Dr. Deanne Greenwood B.Sc., GAICD, MBA, Ph.D.VP of Bus. Devel. & Intellectual Property
Mr. Stefan RossCompany Sec.

Profitability and management effectiveness

Profit margin


Operating margin


Return on assets


Return on equity


Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Patrys is and its enterprise value is .

Companies similar to Patrys (PAB)

Patrys (ASX:PAB) Frequently Asked Questions

1. What is Patrys's Stock Symbol?

Patrys trades on ASX under the ticker symbol "PAB".

2. What is Patrys's stock price today?

One share of PAB stock can currently be purchased for approximately $0.038.

3. How can I contact Patrys?

Patrys's mailing address is 100 Albert Road Level 4 Melbourne VIC 3205 Australia. The company can be reached via phone at 61 3 9670 3273.

4. What is Patrys's official website?

The official website of Patrys is

5. Which share registry manages Patrys's stock?